Raymond James & Associates’s Inovio Pharmaceuticals INO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-873
Closed -$5.35K 3915
2023
Q4
$5.35K Sell
873
-417
-32% -$2.55K ﹤0.01% 3759
2023
Q3
$6.02K Buy
1,290
+17
+1% +$79 ﹤0.01% 3735
2023
Q2
$6.82K Sell
1,273
-66
-5% -$354 ﹤0.01% 3760
2023
Q1
$13.2K Buy
1,339
+64
+5% +$630 ﹤0.01% 3769
2022
Q4
$23.9K Sell
1,275
-321
-20% -$6.01K ﹤0.01% 3705
2022
Q3
$33K Sell
1,596
-785
-33% -$16.2K ﹤0.01% 3693
2022
Q2
$49K Buy
2,381
+8
+0.3% +$165 ﹤0.01% 3732
2022
Q1
$102K Sell
2,373
-222
-9% -$9.54K ﹤0.01% 3767
2021
Q4
$155K Sell
2,595
-65
-2% -$3.88K ﹤0.01% 3733
2021
Q3
$229K Buy
2,660
+775
+41% +$66.7K ﹤0.01% 3564
2021
Q2
$210K Sell
1,885
-92
-5% -$10.2K ﹤0.01% 3628
2021
Q1
$220K Sell
1,977
-553
-22% -$61.5K ﹤0.01% 3518
2020
Q4
$269K Buy
2,530
+19
+0.8% +$2.02K ﹤0.01% 3157
2020
Q3
$350K Buy
2,511
+459
+22% +$64K ﹤0.01% 2841
2020
Q2
$664K Buy
2,052
+205
+11% +$66.3K ﹤0.01% 2410
2020
Q1
$165K Hold
1,847
﹤0.01% 3081
2019
Q4
$73K Buy
1,847
+340
+23% +$13.4K ﹤0.01% 3461
2019
Q3
$37K Buy
1,507
+209
+16% +$5.13K ﹤0.01% 3442
2019
Q2
$46K Hold
1,298
﹤0.01% 3449
2019
Q1
$58K Sell
1,298
-818
-39% -$36.6K ﹤0.01% 3418
2018
Q4
$102K Buy
2,116
+1,165
+123% +$56.2K ﹤0.01% 3277
2018
Q3
$63K Buy
+951
New +$63K ﹤0.01% 3428
2017
Q2
Sell
-843
Closed -$67K 3214
2017
Q1
$67K Sell
843
-33
-4% -$2.62K ﹤0.01% 3059
2016
Q4
$73K Sell
876
-183
-17% -$15.3K ﹤0.01% 3004
2016
Q3
$118K Buy
1,059
+116
+12% +$12.9K ﹤0.01% 2930
2016
Q2
$105K Buy
943
+85
+10% +$9.46K ﹤0.01% 2772
2016
Q1
$90K Buy
+858
New +$90K ﹤0.01% 2707